PEACCEL listed in the Global AI-based Drug Discovery Market Report 2021: Market report by Cision (NYSE: CISN).

6 April 2021

PEACCEL listed in the Global AI-based Drug Discovery Market Report 2021:  Market report by Cision (NYSE: CISN).

https://www.prnewswire.com/news-releases/global-ai-based-drug-discovery-market-report-2021-current-market-landscape-and-future-potential-of-the-players-engaged-in-offering-ai-based-services-platforms-and-tools—forecast-to-2030-301231782.html


PEACCEL awarded by Wealth & Finance

15 February 2021

PEACCEL has just received two Artificial Intelligence Awards from Wealth & Finance :

 – Best Drug Development AI Partner 2020

– Most Innovative Clinical Data Science Platform : innov’SAR

Digital Magazine Link


PEACCEL awarded by CIO Review

25 January 2021

PEACCEL has just been nominated as most promising biotech solutions providers in Europe 2021.

Click the links below for more details:

HTML Link
Digital Magazine Link


PRAXISforum Enzymes for Industrial Applications 2020, 4-5 February 2020, Frankfurt, Germany

3 February 2020

Meet PEACCEL at PRAXISforum Enzymes for Industrial Applications 2020.

Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.


Protein Engineering Congress EU, 12-13 November 2019, Frankfurt am Main, Germany

18 October 2019

Meet PEACCEL at Protein Engineering Congress EU.

Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.


Enzyme Engineering XXV, 15-19 September 2019, Whistler, British Columbia, Canada

14 September 2019

Meet PEACCEL at Enzyme Engineering XXV.

Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.